非血液がんの世界市場2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Non-Hematological Cancers Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0GIR-01381 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、非血液がんの世界市場を広く調査・分析し、今後の市場展望をまとめております。非血液がんの種類別市場規模（化学療法、外科、放射線療法、その他）、用途別市場規模（病院、腫瘍治療センター、外来手術センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Novartis、Johnson & Johnson、Pfizer、Astellas Pharma、Bristol-Myers Squibb、Amgen、Roche ・地域別グローバル市場分析 2015年-2020年 ・非血液がんの北米市場（アメリカ、カナダ、メキシコ） ・非血液がんのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・非血液がんのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・非血液がんの南米市場（ブラジル、アルゼンチン） ・非血液がんの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：化学療法、外科、放射線療法、その他 ・用途別分析：病院、腫瘍治療センター、外来手術センター、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Non-Hematological Cancers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Non-Hematological Cancers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Non-Hematological Cancers market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Non-Hematological Cancers market has been segmented into:
Chemotherapy
Surgery
Radiation Therapy
Others

By Application, Non-Hematological Cancers has been segmented into:
Hospitals
Oncology Treatment Centre
Ambulatory Surgery Centers
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Non-Hematological Cancers market presented in the report. This section sheds light on the sales growth of different regional and country-level Non-Hematological Cancers markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Non-Hematological Cancers market.

The report offers in-depth assessment of the growth and other aspects of the Non-Hematological Cancers market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Non-Hematological Cancers Market Share Analysis
Non-Hematological Cancers competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Non-Hematological Cancers sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Non-Hematological Cancers sales, revenue and market share for each player covered in this report.

The major players covered in Non-Hematological Cancers are:
Novartis
Johnson & Johnson
Pfizer
Astellas Pharma
Bristol-Myers Squibb
Amgen
Roche

レポート目次

---

Table of Contents

1 Non-Hematological Cancers Market Overview
1.1 Product Overview and Scope of Non-Hematological Cancers
1.2 Classification of Non-Hematological Cancers by Type
1.2.1 Global Non-Hematological Cancers Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Non-Hematological Cancers Revenue Market Share by Type in 2019
1.2.3 Chemotherapy
1.2.4 Surgery
1.2.5 Radiation Therapy
1.2.6 Others
1.3 Global Non-Hematological Cancers Market by Application
1.3.1 Overview: Global Non-Hematological Cancers Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Oncology Treatment Centre
1.3.4 Ambulatory Surgery Centers
1.3.5 Others
1.4 Global Non-Hematological Cancers Market by Regions
1.4.1 Global Non-Hematological Cancers Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Non-Hematological Cancers (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Non-Hematological Cancers Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Non-Hematological Cancers Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Non-Hematological Cancers Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Non-Hematological Cancers Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Non-Hematological Cancers Status and Prospect (2015-2025)
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Non-Hematological Cancers Revenue, Gross Margin and Market Share (2018-2019)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Johnson & Johnson SWOT Analysis
2.2.4 Johnson & Johnson Product and Services
2.2.5 Johnson & Johnson Non-Hematological Cancers Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer SWOT Analysis
2.3.4 Pfizer Product and Services
2.3.5 Pfizer Non-Hematological Cancers Revenue, Gross Margin and Market Share (2018-2019)
2.4 Astellas Pharma
2.4.1 Astellas Pharma Details
2.4.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Astellas Pharma SWOT Analysis
2.4.4 Astellas Pharma Product and Services
2.4.5 Astellas Pharma Non-Hematological Cancers Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bristol-Myers Squibb
2.5.1 Bristol-Myers Squibb Details
2.5.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bristol-Myers Squibb SWOT Analysis
2.5.4 Bristol-Myers Squibb Product and Services
2.5.5 Bristol-Myers Squibb Non-Hematological Cancers Revenue, Gross Margin and Market Share (2018-2019)
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Amgen SWOT Analysis
2.6.4 Amgen Product and Services
2.6.5 Amgen Non-Hematological Cancers Revenue, Gross Margin and Market Share (2018-2019)
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Roche SWOT Analysis
2.7.4 Roche Product and Services
2.7.5 Roche Non-Hematological Cancers Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Non-Hematological Cancers Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Non-Hematological Cancers Players Market Share
3.2.2 Top 10 Non-Hematological Cancers Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Non-Hematological Cancers Revenue and Market Share by Regions
4.2 North America Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
4.3 Europe Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
4.5 South America Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
5 North America Non-Hematological Cancers Revenue by Countries
5.1 North America Non-Hematological Cancers Revenue by Countries (2015-2020)
5.2 USA Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
5.3 Canada Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
5.4 Mexico Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
6 Europe Non-Hematological Cancers Revenue by Countries
6.1 Europe Non-Hematological Cancers Revenue by Countries (2015-2020)
6.2 Germany Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
6.3 UK Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
6.4 France Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
6.5 Russia Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
6.6 Italy Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Non-Hematological Cancers Revenue by Countries
7.1 Asia-Pacific Non-Hematological Cancers Revenue by Countries (2015-2020)
7.2 China Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
7.3 Japan Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
7.4 Korea Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
7.5 India Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
8 South America Non-Hematological Cancers Revenue by Countries
8.1 South America Non-Hematological Cancers Revenue by Countries (2015-2020)
8.2 Brazil Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
8.3 Argentina Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Non-Hematological Cancers by Countries
9.1 Middle East & Africa Non-Hematological Cancers Revenue by Countries (2015-2020)
9.2 Saudi Arabia Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
9.3 UAE Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
9.4 Egypt Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
9.5 South Africa Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Non-Hematological Cancers Revenue and Market Share by Type (2015-2020)
10.2 Global Non-Hematological Cancers Market Forecast by Type (2019-2024)
10.3 Chemotherapy Revenue Growth Rate (2015-2025)
10.4 Surgery Revenue Growth Rate (2015-2025)
10.5 Radiation Therapy Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global Non-Hematological Cancers Market Segment by Application
11.1 Global Non-Hematological Cancers Revenue Market Share by Application (2015-2020)
11.2 Non-Hematological Cancers Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Oncology Treatment Centre Revenue Growth (2015-2020)
11.5 Ambulatory Surgery Centers Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Non-Hematological Cancers Market Size Forecast (2021-2025)
12.1 Global Non-Hematological Cancers Market Size Forecast (2021-2025)
12.2 Global Non-Hematological Cancers Market Forecast by Regions (2021-2025)
12.3 North America Non-Hematological Cancers Revenue Market Forecast (2021-2025)
12.4 Europe Non-Hematological Cancers Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Non-Hematological Cancers Revenue Market Forecast (2021-2025)
12.6 South America Non-Hematological Cancers Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Non-Hematological Cancers Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Non-Hematological Cancers Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Non-Hematological Cancers by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Non-Hematological Cancers Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Non-Hematological Cancers Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Novartis Corporate Information, Location and Competitors
Table 6. Novartis Non-Hematological Cancers Major Business
Table 7. Novartis Non-Hematological Cancers Total Revenue (USD Million) (2017-2018)
Table 8. Novartis SWOT Analysis
Table 9. Novartis Non-Hematological Cancers Product and Solutions
Table 10. Novartis Non-Hematological Cancers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Johnson & Johnson Corporate Information, Location and Competitors
Table 12. Johnson & Johnson Non-Hematological Cancers Major Business
Table 13. Johnson & Johnson Non-Hematological Cancers Total Revenue (USD Million) (2018-2019)
Table 14. Johnson & Johnson SWOT Analysis
Table 15. Johnson & Johnson Non-Hematological Cancers Product and Solutions
Table 16. Johnson & Johnson Non-Hematological Cancers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Pfizer Corporate Information, Location and Competitors
Table 18. Pfizer Non-Hematological Cancers Major Business
Table 19. Pfizer Non-Hematological Cancers Total Revenue (USD Million) (2017-2018)
Table 20. Pfizer SWOT Analysis
Table 21. Pfizer Non-Hematological Cancers Product and Solutions
Table 22. Pfizer Non-Hematological Cancers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Astellas Pharma Corporate Information, Location and Competitors
Table 24. Astellas Pharma Non-Hematological Cancers Major Business
Table 25. Astellas Pharma Non-Hematological Cancers Total Revenue (USD Million) (2017-2018)
Table 26. Astellas Pharma SWOT Analysis
Table 27. Astellas Pharma Non-Hematological Cancers Product and Solutions
Table 28. Astellas Pharma Non-Hematological Cancers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 30. Bristol-Myers Squibb Non-Hematological Cancers Major Business
Table 31. Bristol-Myers Squibb Non-Hematological Cancers Total Revenue (USD Million) (2017-2018)
Table 32. Bristol-Myers Squibb SWOT Analysis
Table 33. Bristol-Myers Squibb Non-Hematological Cancers Product and Solutions
Table 34. Bristol-Myers Squibb Non-Hematological Cancers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Amgen Corporate Information, Location and Competitors
Table 36. Amgen Non-Hematological Cancers Major Business
Table 37. Amgen Non-Hematological Cancers Total Revenue (USD Million) (2017-2018)
Table 38. Amgen SWOT Analysis
Table 39. Amgen Non-Hematological Cancers Product and Solutions
Table 40. Amgen Non-Hematological Cancers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Roche Corporate Information, Location and Competitors
Table 42. Roche Non-Hematological Cancers Major Business
Table 43. Roche Non-Hematological Cancers Total Revenue (USD Million) (2017-2018)
Table 44. Roche SWOT Analysis
Table 45. Roche Non-Hematological Cancers Product and Solutions
Table 46. Roche Non-Hematological Cancers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Global Non-Hematological Cancers Revenue (Million USD) by Players (2015-2020)
Table 48. Global Non-Hematological Cancers Revenue Share by Players (2015-2020)
Table 49. Global Non-Hematological Cancers Revenue (Million USD) by Regions (2015-2020)
Table 50. Global Non-Hematological Cancers Revenue Market Share by Regions (2015-2020)
Table 51. North America Non-Hematological Cancers Revenue by Countries (2015-2020)
Table 52. North America Non-Hematological Cancers Revenue Market Share by Countries (2015-2020)
Table 53. Europe Non-Hematological Cancers Revenue (Million USD) by Countries (2015-2020)
Table 54. Asia-Pacific Non-Hematological Cancers Revenue (Million USD) by Countries (2015-2020)
Table 55. South America Non-Hematological Cancers Revenue by Countries (2015-2020)
Table 56. South America Non-Hematological Cancers Revenue Market Share by Countries (2015-2020)
Table 57. Middle East and Africa Non-Hematological Cancers Revenue (Million USD) by Countries (2015-2020)
Table 58. Middle East and Africa Non-Hematological Cancers Revenue Market Share by Countries (2015-2020)
Table 59. Global Non-Hematological Cancers Revenue (Million USD) by Type (2015-2020)
Table 60. Global Non-Hematological Cancers Revenue Share by Type (2015-2020)
Table 61. Global Non-Hematological Cancers Revenue Forecast by Type (2021-2025)
Table 62. Global Non-Hematological Cancers Revenue by Application (2015-2020)
Table 63. Global Non-Hematological Cancers Revenue Share by Application (2015-2020)
Table 64. Global Non-Hematological Cancers Revenue Forecast by Application (2021-2025)
Table 65. Global Non-Hematological Cancers Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Non-Hematological Cancers Picture
Figure 2. Global Non-Hematological Cancers Revenue Market Share by Type in 2019
Figure 3. Chemotherapy Picture
Figure 4. Surgery Picture
Figure 5. Radiation Therapy Picture
Figure 6. Others Picture
Figure 7. Non-Hematological Cancers Revenue Market Share by Application in 2019
Figure 8. Hospitals Picture
Figure 9. Oncology Treatment Centre Picture
Figure 10. Ambulatory Surgery Centers Picture
Figure 11. Others Picture
Figure 12. Global Non-Hematological Cancers Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Non-Hematological Cancers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Non-Hematological Cancers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Non-Hematological Cancers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Non-Hematological Cancers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Non-Hematological Cancers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Non-Hematological Cancers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Non-Hematological Cancers Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Non-Hematological Cancers Revenue Market Share in 2019
Figure 21. Global Top 10 Players Non-Hematological Cancers Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Non-Hematological Cancers Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Non-Hematological Cancers Revenue Market Share by Regions (2015-2020)
Figure 25. Global Non-Hematological Cancers Revenue Market Share by Regions in 2018
Figure 26. North America Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
Figure 27. Europe Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
Figure 29. South America Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
Figure 31. North America Non-Hematological Cancers Revenue Market Share by Countries (2015-2020)
Figure 32. North America Non-Hematological Cancers Revenue Market Share by Countries in 2019
Figure 33. USA Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
Figure 34. Canada Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
Figure 36. Europe Non-Hematological Cancers Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Non-Hematological Cancers Revenue Market Share by Countries in 2019
Figure 38. Germany Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
Figure 39. UK Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
Figure 40. France Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
Figure 41. Russia Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
Figure 42. Italy Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Non-Hematological Cancers Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Non-Hematological Cancers Revenue Market Share by Countries in 2019
Figure 45. China Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
Figure 46. Japan Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
Figure 47. Korea Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
Figure 48. India Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
Figure 50. South America Non-Hematological Cancers Revenue Market Share by Countries (2015-2020)
Figure 51. South America Non-Hematological Cancers Revenue Market Share by Countries in 2019
Figure 52. Brazil Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Non-Hematological Cancers Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Non-Hematological Cancers Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
Figure 57. UAE Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Non-Hematological Cancers Revenue and Growth Rate (2015-2020)
Figure 60. Global Non-Hematological Cancers Revenue Share by Type (2015-2020)
Figure 61. Global Non-Hematological Cancers Revenue Share by Type in 2019
Figure 62. Global Non-Hematological Cancers Market Share Forecast by Type (2021-2025)
Figure 63. Global Chemotherapy Revenue Growth Rate (2015-2020)
Figure 64. Global Surgery Revenue Growth Rate (2015-2020)
Figure 65. Global Radiation Therapy Revenue Growth Rate (2015-2020)
Figure 66. Global Others Revenue Growth Rate (2015-2020)
Figure 67. Global Non-Hematological Cancers Revenue Share by Application (2015-2020)
Figure 68. Global Non-Hematological Cancers Revenue Share by Application in 2019
Figure 69. Global Non-Hematological Cancers Market Share Forecast by Application (2021-2025)
Figure 70. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 71. Global Oncology Treatment Centre Revenue Growth Rate (2015-2020)
Figure 72. Global Ambulatory Surgery Centers Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Non-Hematological Cancers Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Non-Hematological Cancers Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Non-Hematological Cancers Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Non-Hematological Cancers Revenue Market Forecast (2021-2025)
Figure 78. Europe Non-Hematological Cancers Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Non-Hematological Cancers Revenue Market Forecast (2021-2025)
Figure 80. South America Non-Hematological Cancers Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Non-Hematological Cancers Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel

---